Safety and Efficacy of Cannabis in Autism Spectrum Disorder

Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months.

Detalles Bibliográficos
Autores principales: Ganesh, Abhinaya, Shareef, Safiullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pediatric Neurology Briefs Publishers 2020
Materias:
Neurodevelopmental Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759327/
https://www.ncbi.nlm.nih.gov/pubmed/33376294
http://dx.doi.org/10.15844/pedneurbriefs-34-25
Descripción
Sumario:Investigators from the Soroka University Medical Centre, The Hebrew University of Jerusalem, and Tikun Olam Ltd. in Israel studied the safety and efficacy of medical cannabis treatment on 188 patients with autism spectrum disorder (ASD) for six months.

Ejemplares similares